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INTRODUCTION 
 Diabetes mellitus is a major medical problem throughout the world. 
Diabetes causes an array of long-term systemic complications, which have 
considerable impact on both the patient and the society because it typically 
affects individuals in their most productive years. Ophthalmic complications of 
diabetes include corneal abnormalities, glaucoma, iris neovascularization, 
cataracts, and neuropathies. However, the most common and potentially most 
blinding of these complications is diabetic retinopathy.  Cataract occurs more 
frequently and at an earlier age in diabetic than in non-diabetic patients. 
Cataract  surgery in diabetic patients may become necessary, not only to 
improve vision but also to allow assessment  and treatment of diabetic 
retinopathy. Compared to non-diabetic patients, visual outcome after cataract  
surgery was reported to be worse in diabetic patients - especially in those with 
diabetic retinopathy. Some  investigators also found an increased progression 
of retinopathy and a higher incidence of macular oedema  after cataract surgery 
but others did not .Most of these studies were retrospective, and  either 
different  operation techniques - such as ICCE or ECCE, phacoemulsification 
(in a few recent studies), or different  patient populations such as diabetic 
patients without retinopathy and with retinopathy of various degrees –  may 
explain the different outcomes. Surgical outcome in patients without diabetic 
retinopathy is comparable to non-diabetic patients, and the outcome of patients 
with retinopathy appears to depend on the degree of  retinopathy at the time of 
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surgery .In general, patients with mild non-proliferative retinopathy without 
laser indication have been proposed to have a good prognosis. Patients with 
mild-to-moderate diabetic  retinopathy also represent a large proportion of 
patients with diabetic retinopathy. We therefore planned to valuate the visual 
outcome, the progression of retinopathy, and the incidence of macular oedema 
1 year after small incision  cataract  surgery  and intraocular lens implantation 
in a homogenous group of patients with mild-to-moderate diabetic retinopathy 
without clinically significant macular oedema at baseline. Progression of 
retinopathy and incidence of  macular edema  were compared  with the non-
operated fellow eyes. 
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PATHOPHYSIOLOGY OF DIABETIC RETINOPATHY  
 
 The exact mechanism by which diabetes causes retinopathy remains 
unclear, but several theories have been postulated to explain the typical course 
and history of the disease.  
Platelets and blood viscosity  
 The variety of hematologic abnormalities seen in diabetes, such as 
increased erythrocyte aggregation, decreased red blood cell deformability,  
increased platelet aggregation, and adhesion, predispose to sluggish circulation, 
endothelial damage, and focal capillary occusion. This leads to retinal 
ischemia, which, in turn, contributes to the development of diabetic 
retinopathy.  
Aldose reductase and vasoproliferative factors  
 Fundamentally, diabetes mellitus causes abnormal glucose metabolism 
as a result of decreased levels or activity of insulin. Increased levels of blood 
glucose are thought to have a structural and physiologic effect on retinal 
capillaries causing them to be both functionally and anatomically incompetent.  
 A persistent increase in blood glucose levels shunts excess glucose into 
the aldose reductase pathway in certain tissues, which converts sugars into 
alcohol (e.g., glucose into sorbitol, galactose to dulcitol). Intramural pericytes 
of retinal capillaries seem to be affected by this increased level of sorbitol, 
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eventually leading to the loss of its primary function (i.e., auto regulation of 
retinal capillaries).  
 Loss of function of pericytes results in weakness and eventual saccular 
out pouching of capillary walls. These microaneurysms are the earliest 
detectable signs of diabetic retinopathy.  
 Increased permeability of these vessels results in leakage of fluid and 
proteinaeous material, which clinically appears as retinal thickening and 
exudaes. If the swelling and exudation would happen to involve the macula, a 
diminution in central vision may be experienced. Macular edema is the most 
common cause of vision loss in patients with nonproliferative diabetic 
retinopathy.  
 Another theory to explain the development of macular edema deals with 
the increased levels of diacylglycerol from the shunting of excess glucose. This 
is thought to activate protein kinase C, which, in turn, affects retinal blood 
dynamics, especially permeability and flow, leading to fluid leakage and retinal 
thickening.  
 As the disease progresses, eventual closure of the retinal capillaries 
occurs, leading to hypoxia. Infarction of the nerve fiber layer leads to the 
formation of cotton-wool spots with associated stasis in axoplasmic flow.  
 More extensive retinal hypoxia triggers compensatory mechanisms 
within the eye to provide enough oxygen to tissues. Venous caliber 
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abnormalities, such as venous beading, loops, and dilation, signify increasing 
hypoxia and almost always are seen bordering the areas of capillary 
nonperfusion. Intraretinal microvascular abnormalities represent either new 
vessel growth or remodeling of preexisting vessels through endothelial cell 
proliferation within the retinal tissues to act as shunts through areas of 
nonperfusion.  
 Further increase in retinal ischemia trigger the production of 
vasoproliferative factors that stimulate new vessel formation. 
Neovascularization most commonly is observed at the borders of perfused and 
nonperfused retina and most commonly occur along the vascular arcades and at 
the optic nerve head. The new vessels break through and grow along the 
surface of the retina and into the scaffold of the posterior hyaloid face. These 
delicate vessels are disrupted easily by vitreous traction, which leads to 
hemorrhage into the vitreous cavity or the preretinal space.  
 These new blood vessels initially are associated with a small amount of 
fibroglial tissue formation. However, as the density of the neovascular frond 
increases, so does the degree of fibrous tissue formation. In later stages, the 
vessels may regress leaving only networks of avascular fibrous tissue adherent 
to both the retina and the posterior hyaloids face. As the vitreous contracts, it 
may exert tractional forces on the retina via these fibroglial connections. 
Traction may cause retinal edema, retinal heterotropia, and both tractional 
retinal detachments and retinal tear formation with subsequent detachment.  
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EPIDEMIOLOGY OF DIABETIC RETINOPATHY  
Frequency 
 Diabetic retinopathy is emerging as one of the important causes of 
blindness in both developing and developed countries. The World Health 
Organization   has estimated that, the number of adults with diabetes in the 
world would increase alarmingly: from 135million in 1995 to 300 million in 
2025. 
 In India, this increase is expected to be the greatest; nearly 195% from 
18 million in 1995 to 54 million in 2025. 
 Studies done by the Indian  council  of  medical research in the early 
1970’s had shown the prevalence of diabetes in India to be 2.5% in  the urban 
population and 1.5% in the rural population. However recent  reports have 
shown the prevalence to  be in the range of 12 to 14% in the urban population. 
Of these patients  with diabetes, over 20% are expected   to be suffering from 
diabetic retinopathy. The prevalence of diabetes  in the rural population is 
expected to  be about 5%. 
Race 
 An increased risk of diabetic retinopathy appears to exist in patients with 
Native American, Hispanic, and African American heritage. 
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Sex 
 Sex does not appear to have any affect on the development of diabetes 
or diabetic retinopathy. 
Age 
 With increasing duration of diabetes, or with increasing age since the 
onset of diabetes, there is a higher risk of developing diabetic retinopathy and 
the complications of diabetic retinopathy,  including  diabetic macular edema 
or proliferative diabetic retinopathy. 
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CLINICAL  ASPECTS  OF DIABETIC  RETINOPATHY 
 
History 
 
 In the initial stages, patients are generally asymptomatic; however, in 
the more advanced stages of the disease, patients may experience symptoms, 
including blurred vision, distortion, or visual acuity loss. 
Examination 
 
Microaneurysms  
o Earliest clinical sign of diabetic retinopathy  
 
o Secondary to capillary wall outpouching due to pericyte loss  
 
o Appear as small red dots in the superficial retinal layers   
 
o Fibrin and red blood cell accumulation in the microaneurysm 
lumen  
 
o Rupture produces blot hemorrhages  
 
o May appear yellowish in time as endothelial cells proliferate and 
produce basement membrane 
 
Dot and blot hemorrhages  
 
o Occur as microaneurysms rupture in the deeper layers of the 
retina such as the inner nuclear and outer plexiform layers.  
 
o Appear similar to microaneurysms if they are small; may need 
fluorescein angiography to distinguish between the two  
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 Flame-shaped hemorrhages - Splinter hemorrhages that occur in the 
more superficial nerve fiber layer. 
     Retinal edema and hard exudates - Caused by the breakdown of the 
blood-retina barrier, allowing leakage of serum proteins, lipids, and protein 
from the vessels.  
Cotton-wool spots  
o Nerve fiber layer infarction from occlusion of  precapillary 
arterioles  
 
o Fluorescein angiography - No capillary perfusion  
 
o Frequently bordered by microaneurysms and vascular 
hyperpermeability 
 
Venous loops, venous beading  
 
o Frequently adjacent to areas of nonperfusion  
 
o Reflects increasing retinal ischemia  
 
o Most significant predictor of progression to PDR 
 
Intraretinal microvascular abnormalities  
 
o Remodeled capillary beds without proliferative changes  
 
o Collateral vessels that do not leak on fluorescein angiography  
 
o Usually can be found on the borders of the nonperfused retina 
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CLASSIFICATION OF DIABETIC RETINOPATHY 
 
Early Treatment Diabetic Retinopathy Study [ETDRS] 
 
Levels of Diabetic Retinopathy  
Nonproliferative Diabetic Retinopathy (NPDR) 
 
A. Mild NPDR 
 
•  At least one microaneursym 
B. Moderate NPDR 
• Hemorrhages or microaneurysms (H/Ma),hard  exudates. 
• Soft exudates, Venous beading (VB), and intraretinal microvascular 
abnormalities (IRMAs)  
•  definitely   present. 
     C. Severe NPDR  
• H/ Ma in all 4 quadrants 
• VB in 2 or more quardrants 
• IRMA in at least 1 quadrant 
     D.Very Severe NPDR 
• Any two or more of the following 
• H/ Ma in all 4 quadrants 
• VB in 2 or more quardrants 
• IRMA in at least 1 quadrant 
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Proliferative Diabetic Retinopathy 
E. Early PDR 
• New vessels on the retina 
F.  High-Risk PDR 
• Mild new vessels on the disc (NVD) with vitreous haemorrhage 
• Moderate to severe NVD  (1/4 to ½ disc area) with or without vitreous 
haemorrhage. 
• Moderate neovascularisation  elsewhere (1/2 disc area) with  vitreous 
haemorrhage. 
Clinically Significant Macular Edema (any ONE 
of the following) 
• 1. Thickening of the retina located 500 μm or less from the center of the 
macula 
 
• 2. Hard exudates at 500 μm or less from the center of the macula with 
thickening of the adjacent retina 
• 3. A zone of retinal thickening, one disc area or larger in size, any portion 
of which is one disc diameter or less from the center of  the macula. 
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International Clinical Diabetic Retinopathy (DR) Disease Severity Scale 
Proposed Disease Severity Level Findings Observable With Dilated 
Ophthalmoscopy 
 
No apparent DR 
No abnormalities 
 
Mild nonproliferative DR 
Microaneurysms only 
 
Moderate nonproliferative DR 
More than “mild” but less than 
“severe” 
 
Severe nonproliferative DR 
Any of the following: 
20 or more intraretinal hemorrhages in 
4 quadrants 
Definite venous beading in 2 or more 
quadrants 
Prominent IRMA in 1 or more 
quadrants and no Neovascularization 
Proliferative DR 1 or more of the following: 
Definite neovascularization 
Preretinal or vitreous hemorrhage 
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International clinical classification of diabetic retinopathy 
Severity of diabetic macular edema 
2 major levels, with subcategories for diabetic macular edema 
Proposed Classification Findings Observable Upon Dilated 
Ophthalmoscopy 
 
Diabetic Macular 
Edema Absent 
 
No retinal thickening or hard exudates 
in posterior pole 
 
Diabetic Macular 
Edema Present 
 
Some retinal thickening or hard 
exudates in posterior pole 
 
If diabetic macular edema is present, it can be categorized as follows: 
Proposed Classification Findings Observable Upon Dilated 
Ophthalmoscopy 
Mild Diabetic Macular Edema Some retinal thickening or hard 
exudates in posterior pole but distant 
from the macula  
Moderate Diabetic Macular Edema Retinal thickening or hard exudates 
approaching the center of the macula 
but not involving the center 
Severe Diabetic Macular Edema Retinal thickening or hard exudates 
involving the center of the macula. 
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 Hard exudates are a sign of current or previous macular edema. Diabetic 
macular edema is defined as retinal thickening and this requires a  
3-dimensional assessment that is best performed by a dilated examination using 
slit-lamp bio microscopy and/or stereo fundus photography. 
 Patients with CSME should be considered for laser surgery. Appropriate 
laser  photocoagulation surgery reduces the risk of visual loss by more than 
50%, compared with  no treatment ever. Even in the presence of 20/20 or better 
vision, patients with CSME  should be considered for laser surgery because 
substantial recovery of reduced visual acuity  is relatively unusual following 
treatment. A minority of patients have improvement in  vision. In a majority of 
cases, the goal of treatment with laser photocoagulation is to stabilize the visual 
acuity. When treatment is deferred, as may be desirable when the center  of the 
macula is not involved or imminently threatened, patients should be observed 
closely  (at least every 3 to 4 months) for progression. 
 The diagnosis of diabetic macular edema can be difficult. Macular 
edema is best evaluated  by dilated examination using slit-lamp biomicroscopy 
and/or stereo fundus photography. An ophthalmologist who treats patients for 
this condition should be familiar with relevant  studies and techniques as per 
the ETDRS.  
 Effective surgical treatment and retreatment  protocols have been 
detailed. Preoperatively, the ophthalmologist should discuss with the  patient 
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side effects and risks of treatment. The goal of treatment is to reduce the rate of  
visual loss or stabilize visual acuity. 
 Most patients require more than one treatment session (average: 3-4), 
separated by two to four months, for retinal thickening to resolve. (4). 
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RISK FACTORS FOR DIABETIC RETINOPATHY 
Duration of the diabetes 
 In  type II diabetes , the incidence of diabetic retinopathy increases with 
the duration of the disease. Of patients with type II diabetes, 23% have NPDR 
after 11-13 years, 41% have NPDR after 14-16 years, and 60% have NPDR 
after 16 years. 
Glucose control  
 For patients with non–insulin–dependent diabetes mellitus, the 
American Diabetes Association  has suggested that glycosylated hemoglobin 
levels of less than 7% (reflecting long-term glucose levels) should be the goal 
in all patients to prevent or slow down the onset of diabetes-related 
complications. 
 Renal disease, as evidenced by proteinuria and elevated blood urea 
nitrogen/creatinine levels, is an excellent predictor of the presence of 
retinopathy. This probably is due to the fact that both  conditions are   caused 
by DM-related microangiopathies such that the presence and severity of one   
reflects that of   the other. Evidence suggests that aggressive treatment of the 
nephropathy may have  a beneficial   effect on the progression of diabetic 
retinopathy and neovascular glaucoma.  
 
 Systemic hypertension, in the setting of diabetic nephropathy, correlates 
well with the presence of  retinopathy. Independently, hypertension also may 
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complicate diabetes in that it may result in hypertensive retinal vascular 
changes superimposed on the preexisting diabetic retinopathy, further       
compromising retinal blood flow.  
 Proper management of hyperlipidemia (elevated serum lipids) may 
result in less retinal vessel leakage and hard exudate formation. The reason 
behind this is unclear.  
 Pregnant women without any diabetic retinopathy run a 10% risk of 
developing NPDR during their  pregnancy. Of those with preexisting NPDR, 
4% progress to the proliferative type. 
 In  the  Wisconsin  Epidemiological  Study  of Diabetic  Retinopathy  
cataract  was  the  most  common  cause of  legal  blindness  in  older- onset  
diabetes, and  the  second  most common  cause  in diabetic  patients  with  
younger-onset  disease. 
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PATHOGENESIS OF DIABETIC CATARACT 
 The enzyme aldose reductase  catalyzes the reduction of glucose to 
sorbitol through the polyol pathway, a process linked to the development of 
diabetic cataract. 
 It has been shown that the intracellular accumulation of sorbitol leads to 
osmotic changes resulting in hydropic lens fibers that degenerate and form 
sugar cataracts .In the lens, sorbitol is produced faster than it is converted to 
fructose by the enzyme sorbitol dehydrogenase. In addition, the polar character 
of sorbitol prevents its intracellular removal through diffusion. The increased 
accumulation of sorbitol creates a   hyperosmotic effect that results in an 
infusion of fluid to countervail the osmotic gradient. Animal studies have 
shown that the intracellular accumulation of polyols leads to a collapse and 
liquefaction of lens fibers, which ultimately results in the formation of lens 
opacities. 
 Furthermore, studies have shown that osmotic stress in the lens caused 
by sorbitol accumulation induces apoptosis in lens epithelial cells  leading to 
the development of cataract. 
 A study performed by Oishi et al. investigated whether aldose reductase 
is linked to the development of adult diabetic cataracts. Levels of aldose 
reductase in red blood cells of patients under 60 years of age with a short 
duration of diabetes were positively correlated with the prevalence of posterior 
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subcapsular cataracts. A negative correlation has been shown in diabetic 
patients between the amount of aldose reductase in erythrocytes and the density 
of lens epithelial cells, which are known to be decreased in diabetics compared 
to nondiabetics suggesting a potential role of aldose reductase in this 
pathomechanism. 
 The polyol pathway has been described as the primary mediator of 
diabetes-induced oxidative stress in the lens .Osmotic stress caused by the 
accumulation of sorbitol induces stress in the endoplasmic reticulum the 
principal site of protein synthesis, ultimately leading to the generation of free 
radicals. There are numerous recent publications that describe oxidative stress 
damage to lens fibers by free radical scavengers in diabetics. However, there is 
no evidence that these free radicals initiate the process of cataract formation but 
rather accelerate and aggravate its development. Hydrogen peroxide is elevated 
in the aqueous humor of diabetics and induces the generation of hydroxyl 
radicals .Furthermore, increased glucose levels in the aqueous humor may 
induce glycation of lens proteins, a process resulting in the generation of 
superoxide radicals and in the formation of advanced glycation endproducts. 
By interaction with cell surface receptors such as receptor for advanced 
glycation endproducts in the epithelium of the lens further hydrogen peroxide 
is generated. 
 In addition to increased levels of free radicals, diabetic lenses show an 
impaired antioxidant capacity, increasing their susceptibility to oxidative stress. 
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The loss of antioxidants is exacerbated by glycation and inactivation of lens 
antioxidant enzymes like superoxide dismutases.  
 In conclusion, a variety of publications support the hypothesis that the 
initiating mechanism in diabetic cataract formation is the generation of polyols 
from glucose by aldose reductase  which results in increased osmotic stress in 
the lens fibers leading to their swelling and rupture. 
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STUDIES   REGARDING THE INCIDENCE  OF   
DIABETIC  CATARACT 
 
 Several clinical studies have shown that cataract development occurs 
more frequently and at an earlier age in diabetic compared to nondiabetic 
patients Data from the Framingham and other eye studies indicate a three to 
fourfold increased prevalence of cataract in patients with diabetes under the age 
of 65, and up to a twofold excess prevalence in patients above 65 .The risk is 
increased in patients with longer duration of diabetes and in those with poor 
metabolic control. A special type of cataract—known as snowflake cataract—is 
seen predominantly in young type 1 diabetic patients and tends to progress 
rapidly. Cataracts may be reversible in young diabetics with improvement in 
metabolic control. The most frequently seen type of cataract in diabetics is the 
age-related or senile variety, which tends to occur earlier and progresses more 
rapidly than in nondiabetics.  
 The Wisconsin Epidemiologic Study of Diabetic Retinopathy 
investigated the incidence of cataract extraction in people with diabetes. 
Furthermore, additional factors associated with higher risk of cataract surgery 
were determined. The 10-year cumulative incidence of cataract surgery was 
8.3% in patients suffering from type 1 diabetes and 24.9% in those from type 2 
diabetes. Predictors of cataract surgery included age, severity of diabetic 
retinopathy and proteinuria in type 1 diabetics whereas age and use of  insulin 
were associated with increased risk in type 2 diabetics. 
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 A follow-up examination of the Beaver Dam Eye Study cohort, 
consisting of 3684 participants 43 years of age and older, performed 5 years 
after the baseline evaluation showed an association between diabetes mellitus 
and cataract formation . In the study, the incidence and progression of cortical 
and posterior subcapsular cataract was associated with diabetes. In addition, 
increased levels of glycated hemoglobin were shown to be associated with an 
increased risk of nuclear and cortical cataracts. 
 In a further analysis of the Beaver Dam Eye study the prevalence of 
cataract development was studied in a population of 4926 adults . Diabetic 
patients were more likely to develop cortical lens opacities and showed a 
higher rate of previous cataract surgery than nondiabetics. The analysis of the 
data proved that longer duration of diabetes was associated with an increased 
frequency of cortical cataract as well as an increased frequency of cataract 
surgery. 
 The aim of the population-based cross-sectional Blue Mountains Eye 
Study was to examine the relationship between nuclear, cortical, and posterior 
subcapsular cataract in 3654 participants between the years 1992 to 1994. The 
study supported the previous findings of the harmful effects of diabetes on the 
lens. Posterior subcapsular cataract was shown to be statistically significantly 
associated with diabetes. However, in contrast to the Beaver Dam Eye Study, 
nuclear cataract showed a weak, not statistically significant, association after 
adjusting for other known cataract risk factors.   
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 A population-based cohort study of 2335 people older than 49 years of 
age conducted in the Blue Mountains region of Australia investigated 
associations between diabetes and the 5-year incidence of cataract. The results 
of this longitudinal study conducted by the same group of investigators as the 
Blue Mountains Eye Study demonstrated a twofold higher 5-year incidence of 
cortical cataract in participants with impaired fasting glucose. Statistically 
significant associations were shown between incident posterior subcapsular 
cataract and the number of newly diagnosed diabetic patients. 
 The Visual Impairment Project evaluated risk factors for the 
development of cataracts in Australians. The study showed that diabetes 
mellitus was an independent risk factor for posterior subcapsular cataract when 
present for more than 5 years. 
 A goal of the Barbados Eye study was to evaluate the relationship 
between diabetes and lens opacities among 4314 black participants . The 
authors found that diabetes history (18% prevalence) was related to all lens 
changes, especially at younger ages. 
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CATARACT SURGERY IN DIABETIC PATIENTS 
 Approximately  10-15%  of  all  patients  who  undergo cataract  surgery  
are diabetics. 
 The  10-year   cumulative  incidence  of  cataract  surgery  in  patients  
with  diabetes  in  the Wisconsin Epidemiological Study of Diabetic 
Retinopathy  was  two  to  five  times  higher  than  in comparable  non diabetic  
population Cataract  in  diabetic  patients  decreases  the  visual  acuity  and  
makes  an adequate  examination  as  well  as  photocoagulation  of  the  retina  
more difficult  or  nearly  impossible. Therefore, it  is  necessary  and  
important  to  perform  cataract  surgery  for  visual  rehabilitation  and  also  
for diagnostic  and  therapeutic  reasons. This  is  also  postulated  in  other 
studies. 
 Nevertheless,  patients  with  diabetes  are  treated  more  cautiously. 
Some studies  have  shown  that  cataract  surgery  causes  progression  of 
retinopathy  with  new  hemorrhages,  exudates,  and macular  edema. This 
progression  is  also  associated  with  a  poor  visual  outcome  in  about  1 in  
10  patients.  
 These  results  have  not  been  confirmed  in  other  studies, however . 
Recent  studies  have  found  that  the  principal  determinant  of the 
postoperative  visual  outcome  appears  to  be  the  presence  or  absence  of  a  
clinically  significant  macular  edema at  the  time of  surgery. 
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 Diabetics  with  mild  to  moderate  diabetic  retinopathy  represent  a  
high proportion  of  all  patients  with  diabetic  changes  of  the  retina. For  
this reason, we  evaluated  visual  outcome  and  disease  progression  after 
cataract  surgery  in  eyes  with  no or  mild  to  moderate  diabetic  retinopathy  
at baseline  and  1 year  after  surgery. 
  There has been a recent shift in emphasis towards earlier cataract 
extraction in diabetics. Cataract surgery is advisable before lens opacity 
precludes detailed fundus examination.  
 While the overall outcomes of cataract surgery are excellent, patients 
with diabetes may have poorer vision outcomes than those without diabetes. 
Surgery may cause a rapid acceleration of retinopathy, induce rubeosis or lead 
to macular changes, such as macular edema or cystoid macular edema. The 
worst outcomes may occur in operated eyes with active proliferative 
retinopathy and/or preexisting macular edema.  
 In diabetics with or without evidence of diabetic retinopathy the blood-
aqueous barrier is impaired leading to an increased risk of postoperative 
inflammation and development of a sight-threatening macular edema, a process 
that is exacerbated by cataract surgery . Factors that influence the amount of 
postoperative inflammation and the incidence of clinical and angiographic 
cystoid macular edema are duration of surgery, wound size and posterior 
capsular rupture or vitreous loss.  
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 An analysis of Medicare beneficiaries  from the years 1997 through 
2001 revealed that the rate of cystoid macular edema diagnosis after cataract 
surgery was statistically significantly higher in diabetic patients than in 
nondiabetics.  
 Several clinical studies investigated the role of   cataract surgery on the 
progression of  diabetic retinopathy.  
 One year after cataract surgery, the progression rate of diabetic 
retinopathy ranges  between 21% and 32% Borrillo et al. reported a 
progression rate of 25% after a follow-up period of  6 months .A retrospective 
review of 150 eyes of 119 diabetic patients undergoing  cataract   surgery 
showed a similar progression of diabetic retinopathy in 25% of cases within the 
follow-up period of   6–10 months A prospective study evaluating the onset or 
worsening of macula edema at 6 months following cataract surgery in patients 
with mild or moderate nonproliferative diabetic retinopathy reported an 
incidence of 29% (30 of 104 eyes) of macula edema based on angiographic 
data. Krepler et al. investigated 42 patients undergoing cataract surgery and 
reported a progression of diabetic retinopathy of 12% in operated versus 10.8% 
in nonoperated eyes during the follow-up of 12 months . During the same 
follow-up period of 12 months, Squirrell et al. showed that out of 50 patients 
with type 2 diabetes undergoing unilateral cataract surgery 20% of the operated 
eye and 16% of the nonoperated had a progression of diabetic retinopathy. Liao 
and Ku found in a retrospective study that out of 19 eyes with preoperative 
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mild to moderate nonproliferative diabetic retinopathy 11 eyes (57.9%) showed 
progression of diabetic retinopathy 1 year after surgery, while 12 eyes (63.2%) 
had progressed 3 years postoperatively. The progression rates were statistically 
significant when compared to eyes without preoperative retinopathy.   
 A recently published prospective study evaluated eyes from 50 diabetic 
patients with and without retinopathy after cataract surgery by optical 
coherence tomography. The authors reported an incidence of 22% for macula 
edema following cataract surgery (11 of 50 eyes) while macula edema did not 
occur in eyes without retinopathy. When only eyes with confirmed diabetic 
retinopathy were evaluated, the incidence for postoperative macula edema and 
cystoid abnormalities increased to 42% (11 of 26 eyes).  
 Minimal changes from baseline values in center point thickness were 
observed in eyes with no retinopathy.  
 Eyes with moderate nonproliferative diabetic retinopathy or proliferative 
diabetic retinopathy developed an increase from baseline of 145microns and 
131microns at 1 month and 3 month, respectively. The difference in  retinal 
thickening between the 2 groups at 1 and 3 months was statistically significant 
and among patients   with retinopathy inversely correlated with visual acuity 
improvements.(13) 
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Influence  of  diabetes on operative  risk  and  wound  healing 
 The time  worn  aphorism that   postoperative  morbidity is  higher  in 
persons with  diabetes is not  supported  by  clinical  studies. The   conventional 
postulate  that optimal perioperative glycemic  control enhances  the  chances  
of  successful  wound  healing  in  diabetes  is  supported  only  by  
experimental  studies  in  animal  models  of  diabetes. These  studies  implicate  
hyperglycemia and  insulin  deficiency as  factors contributing  to  impaired  
wound  healing. Deficient formation  of  granulation  tissue and  collagen, poor 
tensile  strength of  deep  surgical  wounds and  deficient  capillary  in growth  
into  the  wound have  been  demonstrated. (8) 
Preoperative  evaluation 
 In  planning for  surgery, attention  should  be  directed  towards 
ensuring  that  the general  physical condition  of the  patient  is  as  good  as  
possible. With  the  changes  imposed by  shorter hospital  stays, the  physician  
has  little  time for  careful study and  correction  of related  medical  problems  
before  surgery. 
 The importance  of  pre- admission out-patient  assessment cannot  be  
over emphasized as it allows  for  identification and  treatment  of  potential  
complicating  conditions. 
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Assessment of  cardiac  risk 
 Mortality due  cardiovascular disease increases sharply with age and 
duration of diabetes. Assessment of cardiac risk is a major focus during the pre-
operative evaluation of the patient with diabetes. Particular attention should be 
paid to the history of previous cardiac disease and current cardiac symptoms. 
Surgery should be postponed for 3 to 6 months in patients with the history of 
recent myocardial infarction. 
Assessment   of  renal  disease 
  Renal disease is common in patients with long standing diabetes. 
Caution should be exercised in the use of iodine containing angiographic fluids 
and contrast agents as these are well recognized nephrotoxins in patients with 
significant renal insufficiency. All patients undergoing such studies should be 
kept well hydrated with the additional use of furosemide and mannitol,  if 
needed, to prevent acute renal damage. 
Treatment  of  hypertension 
 Hypertension is a common  accompaniment of diabetes. All reasonable 
efforts should be made to bring the blood pressure under control before 
surgery. As a general rule, anti-hypertensive medications are given on schedule 
on the day of surgery. 
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Diabetes  treatment  during  and  after  surgery 
 Management is considered satisfactory when the blood glucose levels in 
the peri-operative period range between 120-180 mg%. When peri-operative 
glucose values are less than 100%, careful vigilance is necessary to avoid 
hypoglycemia. The wide spread availability of capillary blood glucose 
monitoring has greatly enhanced our ability to control patient’s blood glucose 
level during the peri-operative period.   
Type 1 diabetes 
 Patients with this type of diabetes are a heterogenous group who require 
individualization of their treatment plan. Knowledge of a patient’s previous 
glycemic control, best determined by the glycosylated haemoglobin (HbA1C) 
or fructosamine test, can be of help in determing pre-operative insulin 
requirement. Alterations in nutrition, variable glucose infusion rates, surgical 
stress and post operative pain and immobility are factors that influence post 
operative insulin requirement. For these reasons, insulin is often required 
during peri-operative period by the patient with poorly controlled Type II 
diabetes who is receiving oral agent. 
Type  2  diabetes 
 Surgical patients receiving oral hypoglycemic agents fall into three 
categories:     
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i)  those with good glycemic control-for this group, it is usually sufficient 
to administer the oral agents on the morning of surgery. Long acting  
agents like chlorpropamide should be stopped 24 hrs before surgery in  
favour of a  shorter acting sulphonyl urea.                 
ii) those  with poor glycemic control that will improve when infection 
clears or steroid therapy is discontinued- this group require insulin 
therapy temporarily during the peri-operative period 
iii)  those who actually require insulin therapy with oral agents having failed 
to control hyperglycemia- patients in this group have an absolute need 
for insulin therapy. 
Dietary  management 
 Individualized dietary prescriptions are recommended for the 
hospitalized adult  patients with diabetes. Hospitilization is an ideal opportunity 
to obtain a nutritional assessment and to assist the patient in developing  an 
appropriate dietary plan. Dietary management should be based on a sound 
nutritional assessment of the patient’s caloric needs. (8) 
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AIM 
 To  study  the  effect  of  cataract surgery  and  other  factors  on the  
visual  outcome and  progression  of  diabetic retinopathy  using  the  
nonoperated  contralateral eye  as the  control. 
MATERIALS AND  METHODS  
 Monocular  cataract  surgery  was  performed  in 100 patients who had 
the same degree of retinopathy  in both eyes preoperatively. Patients were 
assigned to 1 of 2 groups as follows: Group A, progression of retinopathy in 
the operated eye caused by cataract surgery; Group B, no progression of 
retinopathy bilaterally, comparable level of progression in both eyes, or more 
progression of retinopathy in the nonoperated eye than in the operated eye. The 
differences between the 2 groups in age, duration of and treatment methods for 
diabetes, renal function  were compared. The 12 months  follow-up included 
evaluation of the progression of retinopathy. 
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INCLUSION  CRITERIA 
1. Patients  with type  2  diabetes  mellitus with  no or mild or moderate  
nonproliferative  diabetic   retinopathy without  CSME.  
2. Patients  with  immature  cataract in  the study eye and  patients with 
either no cataract   or  immature  cataract in  the  fellow  eye  
EXCLUSION  CRITERIA 
1. pseudophakic  patients  
2. patients  having  undergone  previous  laser  treatment. 
3. patients  with  severe NPDR ,PDR 
4. patients with mature cataract 
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PROCEDURE 
PREOPERATIVE  EVALUATION 
 Systemic  evaluation comprised  of  assessment  of  diabetic  status  and  
type of  antidiabetic  medication  used. A detailed history  of  diabetic  control  
over  the  past  5  years was  elicited  to  know whether  the  patient’s  glycemic  
status  was  stable, fluctuating  or  not  controlled  previously.  
 The  present  glycemic  control was  assessed  by  referring all  patients  
who were  known diabetic or  detected  to  be  diabetic  on  routine  
examination, to the  diabetology  department  and  surgical  fitness  obtained  
before  doing  cataract  surgery. 
 For  patients  with  poor  control  of  blood  sugar levels, surgery  was  
deferred until  the  diabetic  status  was  stabilized. Assosciated  conditions  like  
hypertension,cardiac  status and  renal  status  were  given  special  attention  in 
all  cases while  taking  history  and  necessary  investigations, if  
warranted,were  done  before  taking  up  the  patient  for  surgery. 
 A complete ocular examination was performed preoperatively and at the 
final checkup. This examination included the determination of best corrected 
visual acuity using  Snellen  charts, applanation tonometry, slitlamp 
examination, and retinal biomicroscopy at the slitlamp with a 90D  lens. 
Fundus examinations were also performed by direct  and  indirect  
ophthalmoscopy. Diabetic retinopathy was graded accordingly. 
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 Keratometry  and  A  scan  were  done  and  intra ocular lens power  
calculated  using  SRK II formula. 
SURGERY 
 All patients  were  operated  only  by a single senior  surgeon. 
 Routine  SICS with PCIOL  was  planned  in these  patients. 
 Lid  preparation was  done with betadine solution. 
 Bridle suture  was applied 
 Fornix  based  peritomy was done. 
 Incision  was made about 2mm from the limbus with  11 knife  .Scleral  
tunnel incision was made  with crescent knife. 
 Entry  into  anterior  chamber was made   with  the  keratome and  
viscoelastic  material  was  injected  into the  chamber. 
 Continuous curvilinear capsulorrhexis  was  performed.Can opener 
capsulotomy was done in those patients in whom capsulorhexis could not be 
performed. 
 Hydrodissection  was  performed. 
 Nucleus was rotated and brought to the anterior  chamber and delivered 
out  using sandwich technique. 
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 Cortical aspiration  was done  using a 23G simcoe  cannula with  the  
infusion  of  Ringer  Lactate solution.  
 A complete  cortical  aspiration  was  ensured  by  appreciation  of  
fundal  glow. 
 Viscoelastic  material  was  injected  and  capsular  bag  distended .  
 The  integrity  of  capsular  bag  was  ensured  and  then rigid PCIOL 
was inserted in  the  bag. 
 The  cortical  remnants and  viscoelastic  material  were  aspirated and  
anterior  chamber  formed. 
 In the event of posterior capsular rent vitrectomy was performed and 
anterior chamber IOL was inserted. 
 Injection subconjunctival gentamycin 10 mg and dexamethasone 0.5mg 
was  injected  at the  end  and  dressing  applied. 
 All patients  were  treated  with  systemic  antibiotics and  anti-
inflammatory  drugs. 
 Topical  short acting  cycloplegic and  antibiotic  steroid  preparation  
was  applied. 
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 The  patient was  discharged on  the  1st  postoperative day  if there were 
no immediate  postoperative  complications  after  doing  trial vision, slit lamp  
examination, and fundus  examination. 
 Patient  showing  evidence of maculopathic  changes  during  this  
immediate  postoperative  period were considered  to  have  macular  lesions. 
They were  followed  up  with FFA periodically and  necessary  intervention  
with  laser photocoagulation done  at appropriate  time. 
 Postoperatvely all patients were  followed  up  every week  for  6 weeks 
and  then at 12,24,48 weeks. Vision testing  with  pinhole  and  glasses slit  
lamp examination, fundus examination, and  FFA if  needed ,were  done  
during  the  follow  up visits and  postoperative  diabetic  status  monitored. 
 Blood  sugar was  done  during  follow  up  and  postoperative  diabetic  
status  monitored. Refraction  was  done  on  the  6th postoperative week  and  
glasses  for  residual error  and  near vision correction prescribed. 
OUTCOME 
 Outcome variables included changes of visual acuity, changes of 
retinopathy grading as compared  to the  nonoperated  fellow  eye, and 
incidence of   macular  edema. 
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ANALYSIS 
AGE DISTRIBUTION 
 Table 1 
Age,  Years Number of Patients 
41 to49 
50 to59 
60 to 69 
70&Above 
12 
32 
29 
11. 
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 The age of the patients ranged from 41 yrs to 81 yrs, the mean age being 
62 years. The maximum number of patients belong to the age group of 50 to  
59.12 cases belong to the age group 41-49 which is in accordance to  the 
studies that diabetes results in presenile type of cataract. 
 The mean age of surgery in a study by Pollack was 67.1 years.  
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DURATION OF THE DIABETES IN YEARS 
Table 2 
No of years No of Patients 
Found on admission             9 
Less than 2 yrs           13 
2 to 5 yrs           42 
6 to 10 yrs           16 
More than 10 yrs             4 
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 The majority of 42 patients with diabetes for 2 to 5 years had 
uncomplicated cataract. This shows that cataract in diabetes occurs even before 
the onset of retinopathy. 
 The mean duration of diabetes  at the time of surgery was 5.5 years 
whereas Pollock showed the mean duration to be 10.1 years. 
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POSTOPERATIVE   COURSE OF RETINOPATHY IN OPERATED 
AND NON OPERATED EYES 
Table  3 
EYE NO CHANGE PROGRESSION 
 
NO. OF 
EYES 
 
PERCENTAGE
 
NO. OF 
EYES 
 
PERCENTAGE
OPERATED              50            59.6              34               40.4 
NON 
OPERATED 
             72            85.7              12             14.3 
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Postoperative course of retinopathy
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 During the first postoperative year 50 of the operated eyes (59.5%) 
showed ‘no change’ in retinal status and 34 (40.4%) showed ‘progression’of 
diabetic retinopathy. The corresponding findings in the control group were 72 
eyes (85.7%) and  12 eyes (14.3%). 
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 This was comparable to those of Pollock where 61.8% showed ‘no 
change’ and 38.2%  progressed. The corresponding  findings in the control 
group were 87.2% and 12.8%  
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PROGRESSION OF RETINOPATHY DURING THE FIRST YEAR 
AFTER  CATARACT EXTRACTION IN  OPERATED AND NON 
OPERATED EYES 
Table  4 
FOLLOW 
UP PERIOD 
OPERATED      EYE( n=34) NON OPERATED 
EYE(n=12) 
NO. OF 
EYES 
PERCENTAGE NO. OF 
EYES 
PERCENTAGE
2weeks- 3 
months 
             17              50              4            33.3 
4-6   months              10              29.4              5                 41.7 
7-12  months                7              20.6              3               25 
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 The operated eyes showed the highest percentage, that is, about 50% of 
operated patients showed progression of retinopathy from 2weeks to 3 months. 
 43
This was  comparable to the study  done by Pollock who showed 60%  of 
progression from 2 weeks to 3 months.  
REFERENCE  STUDY 
Progression of  diabetic retinopathy during the first year after cataract 
extraction in operated eyes.  
Follow-up period No. of  eyes  progressed 
  (in  percentage ) 
2 weeks - 3 months                           60 
4 - 6 months                           30 
7 - 12 months                           10 
 
 In this  study  there was  maximum  progression  between  the  first   
2 weeks  and  3 months  that is,60%  and  30%  of  eyes  progressed  between   
4  and  6 months. 
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POSTOPERATIVE COURSE OF DIABETIC RETINOPATHY IN RELATION TO ITS 
PREOPERATIVE STATUS
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POSTOPERATIVE COURSE OF DIABETIC RETINOPATHY IN 
RELATION TO ITS PREOPERATIVE   STATUS IN THE OPERATED 
EYE 
Table  5 
PREOPERATIVE 
STATUS 
NO.OF 
EYES(n=84)
NO 
CHANGE(n=50)
PROGRESSION(n=34)
NO  DR 41 36   
(87.8%) 
5     
(12.2%) 
DR 43 14   
(32.6%) 
29     
(67.4%) 
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 In eyes with no evidence of diabetic retinopathy preoperatively there 
was no progression of the retinopathy after cataract surgery in 87.8% of cases 
whereas 12.2% of cases progressed. 
 In eyes with evidence of retinopathy preoperatively there was no 
postoperative progression in 32.6% of  cases whereas it progressed in 67.4% of 
cases. 
 In a study done by Pollock  only 29% of eyes with no evidence of 
retinopathy preoperatively progressed whereas  80%  of eyes with preoperative 
retinopathy progressed after surgery.  
REFERENCE  STUDY 
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 In 71%  of eyes  with  no evidenc of retinopathy  preoperatively  there 
was no change even after  surgery  whereas  only  29%  of  eyes  progressed. 
 In   eyes  with  evidence  of  retinopathy  preoperatively  there was no  
change  in  only  20%  after  surgery whereas  about 80%  of  eyes  progressed. 
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P OS TOP ER ATI VE COUR S E OF DI A B ETI C  R ETI NOP ATHY I N  OP ER ATED EYE AN D 
N ON OP ERA TED EYE
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POSTOPERATIVE PATTERNS OF PROGRESSION OF DIABETIC 
RETINOPATHY IN OPERATED EYE AND NON OPERATED EYE 
Table  6 
COURSE  OF  DR OPERATED EYE NON OPERATED EYE 
No.of 
cases 
Percentage No.of cases percentage 
 
No DR to NPDR 
(5/84) 5.9 (1/84) 1.2 
 
Mild to Mod.NPDR 
(18/84) 21.4 (10/84) 9.5 
 
Mod. To severe 
NPDR 
(11/84) 13.1 (3/84) 3.6 
           Total       (34/84)           40.4       (12/84)           14.3 
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 In  eyes with no DR preoperatively there was progression to NPDR in 
5.9 % of  operated eyes and in 1.2% of  the  non operated  eyes. In the operated 
eyes there   was aggravation of  mild NPDR to moderate NPDR  in  21.4% of 
eyes whereas  in the non operated eyes  9.5 % of eyes had progression from 
mild to moderate  NPDR. In eyes. There was progression  from moderate to 
severe  NPDR in 13.1% of operated eyes the corresponding figures in the non 
operated eyes were 3.6%. 
 This was similar to the findings by Pollock where the maximum 
percentage of eyes (23.6%) showed aggravation of NPDR. 
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REFERENCE  STUDY 
POSTOPERATIVE PATTERNS OF PROGRESSION OF DIABETIC 
RETINOPATHY IN OPERATED EYE AND NON OPERATED EYE 
COURSE  OF  
RETINOPATHY 
OPERATED   
(no. of eyes in %) 
NON OPERATED   
(no. of eyes in %) 
No  DR to NPDR                          9                      4.3 
NPDR to  NPDR                        23.6                      7.1 
No DR to NPDR 
NPDR to PDR 
                         5.6                      1.4 
TOTAL                        38.2                    12.8 
 
 In this study there was  postoperative  progression  in  38.2%  of  eyes  
among  which  23.6% of  eyes  progressed  from one  stage  of  NPDR  to  a 
higher  stage. 
 In the  non operated  eyes  only  12.8%  of  eyes had  postoperative  
progression  of  NPDR ,  7.1%  of  which  progressed  from  one  form  of  
NPDR to another  form  of  NPDR. 
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VISUAL ACUITY RESULTS AFTER  CATARACT SURGERY IN 
RELATION  TO  DIABETIC RETINOPATHY 
Table  7 
VISUAL 
 
ACUITY 
 
NO CHANGE 
 
PROGRESSION 
NO DR 
(n=36) 
DR 
(n=14) 
TOTAL 
(n=50) 
NO DR
(n=5) 
DR 
(n=29) 
TOTAL 
(n=34) 
 
>=6/12 32 
(88.9%) 
10 
(71.4%) 
42 
(84%) 
3 
(60%) 
9 
(31%) 
12 
(35.3%) 
<6/12- 
6/36 
3 
(8.3%) 
3 
(21.4%) 
6 
(12%) 
1 
(20%) 
9 
(31%) 
10 
(34.5%) 
<6/36 1 
(2.7%) 
1 
(7.1%) 
2         
(4%) 
1    
(20%) 
11 
(38%) 
12        
(35.3%) 
 
 In the no  change group 84% of operated eyes had visual  acuity more 
than 6/12 at the end of one year,12% had visual acuity in the range of 6/12 to 
6/36 and 4% had visual acuity less than 6/36.In the eyes which had progression 
of retinopathy only 35.3% had visual acuity more than 6/12,  of 34.5% in the  
range of  less than 6/12 to 6/36 and 35.3% had less than 6/36 at the end of one 
year. 
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 In eyes with no pre-existing retinopathy  and no change in postoperative 
retinal  status a visual acuity of at least 6/12 was achieved  in 60% of the cases. 
By contrast, a relatively high  proportion (38%) of eyes with pre-existing  
diabetic retinopathy and postoperative retinal  deterioration had poor visual 
results of 6/36 or less. 
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REFERENCE STUDY 
VISUAL ACUITY RESULTS AFTER CATARACT SURGERY IN  
RELATION TO DIABETIC RETINOPATHY   
Visual 
Acuity 
No change Progression 
 
NoDR 
(n=38) 
 
DR 
(n=17) 
 
Total 
(n=55) 
 
NoDR(n=9)
 
DR(n=25) 
 
Total(n=34)
>6/12 33 
 (87%) 
12 
(70%) 
45 
(82%) 
6  
(67%) 
7  
(28%) 
13  
(38%) 
6/15-
6/30 
4  
(10%) 
3 
(18%) 
7 
(13%) 
2 
(22%) 
8 
(32%) 
10 
(29%) 
<6/30 1  
(3%) 
2 
(12%) 
3  
(5%) 
1 
(11%) 
10 
(40%) 
11 
(32%) 
 
  
 In eyes  with  no  evidence  of  diabetic  retinopathy  and  no  
postoperative progression  of  retinopathy  status   about  87%  of   eyes  had  
final  visual  acuity  of  more  than  6/12 . 70%  of  eyes  with  preoperative  
retinopathy  and no postoperative  progression  had  more  than  6/12 visual  
acuity. 
 In eyes with  no  postoperative  progression  13%  of  eyes  had  visual  
acuity  ranging  from  6/15  to  6/30 and  5%  had  less  than  6/30  vision  
postoperatively. 
 In the  eyes which  progressed  after  surgery 38% had more  than  6/12 
vision, 29%  had 6/15- 6/30  and  32% had  less than  6/30  vision. 
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INTRAOPERATIVE AND  POSTOPERATIVE COMPLICATIONS 
 Among the intraoperative complications  posterior capsular rent was 
observed in 4 eyes(4.8%) of cases which had an impact on the  postoperative  
progression of retinopathy  and the final visual status. 
 Of the early post operative complications, striate keratopathy was more 
frequent. It was observed in 16 eyes(19%). Iritis was observed in 10 
eyes(12%).  
 Among the late post operative complications, CME occurred  in  8 
eyes(9.5% ) and PCO occurred in 18 eyes(21.4%) of  patients. Ruiz showed an 
incidence of PCO in 41.7% and Pasquier 30%.CME was observed in  32% of 
eyes in a study conducted by Pollack. 
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POST OPERATIVE DIABETIC STATUS 
Table  8 
Glycemic control No of eyes Percentage 
      Good                  45               53.6 
      Fluctuating                  26               31 
      Poor                  13               15.4 
 
POST OPERATIVE DIABETIC STATUS
Good
Fluctuating
Poor
 
 In all these patients, good glycemic control was seen in 53.6% of 
patients.  A fluctuating level was noticed in 31% of  patients and a poor control 
in 15.4% of  patients during the post operative period. CME and progression to 
retinopathy were more related to the fluctuating diabetic control during the post 
operative period. 
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COMPARISON OF CLINICAL FEATURES 
Table  9 
 NO  CHANGE (n=50) PROGRESSION (n=34) 
Mean age, yr (range)              57.8 (45- 64)              61   ( 49-77) 
Mean duration of DM, 
yr (range) 
                4.8              10.4 
No. of. Patients (%)   
Male: female             23:27           16:18 
Management of DM:   
Diet alone                1                1 
Hypoglycemic agents               39 ( 78%)              21 (61.8%) 
Insulin               10  (20%)              12  (35%) 
Vascular disease:   
Hypertension               19             12    
Cardiac                 6               4 
Other diseases:                 2               3   
 
 There was no significant difference between the ‘no change’ and 
‘progression’  group with regard to age,  sex and systemic diseases.the mean 
duration of diabetes was 4.8 yrs in the no change group and 10.4yrs in the 
progression group. Regarding  the management of diabetes  78% of patients in 
no  change group were  managed with  oral hypoglycemic agents  and 20% 
were managed with insulin whereas in the progression group 35% of patients 
were  managed with insulin. 
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RESULTS 
 Of the 100 patients 46 were men and 54 were women. 
 7 patients  lost to follow up. Of the 93 remaining patients cataract 
extraction was unilateral in 84 patients and bilateral in 9.Only the unilateral 
cases were included in the study. 
 The mean age at the time of surgery was 62 years (range 41 to 81 years) 
and the mean duration of diabetes mellitus was 5.5 years. 
 During the first postoperative year 50 of the operated eyes (59.6%) 
showed ‘no change’ in retinal status and 34 (40.4%) showed ‘progression’of 
diabetic retinopathy. The corresponding findings in the control group were  
72 eyes (85.7%) and  12 eyes (14.3%) . 
 In eyes with no evidence of diabetic retinopathy preoperatively there 
was no progression of the retinopathy after cataract surgery in 87.8% of cases 
whereas 12.2% of cases progressed. 
 In eyes with evidence of retinopathy preoperatively there was no 
postoperative progression in 32.6% of cases whereas it progressed in 67.4% of 
cases. 
 The patterns of progression were similar in the operated and 
nonoperated eyes. 
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 In eyes with no DR preoperatively there was progression to NPDR in 
5.9 %  of  operated eyes and in 1.2%  of  the  non operated eyes. 
 In the operated eyes there was aggravation of  mild NPDR to moderate 
NPDR  in 21.4% of eyes whereas  in the non operated eyes  9.5% of eyes had 
progression from mild to moderate  NPDR. 
  There was progression  from moderate to severe  NPDR in 13.1% of 
operated eyes  and the corresponding figures in the non operated eyes were 
3.6%. 
 In eyes with no pre-existing  retinopathy and no change in postoperative 
retinal status a visual acuity of at least  6/12 was achieved  in 88.9% of the 
cases. By contrast, a relatively high  proportion (38%) of eyes with pre-existing  
diabetic retinopathy and postoperative retinal deterioration had poor visual 
results of 6/36 or  less. 
 Among the intra operative  complications  posterior capsular rent was 
observed in 4.8% of cases.  Of the early post operative complications, striate 
keratopathy  was observed in 19%  of  patients. Iritis was observed in 12% of 
patients. 
  Among the late post operative complications, CME occurred on 9.5%  
and PCO occurred in 21.4% of patients. 
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 Regarding the postoperative diabetic status  good glycemic control was 
seen in 53.6% of patients.  A fluctuating level was noticed in 31% of  patients 
and a poor control in 15.4% of  patients.   
 Among the operated patients there was no difference between the two 
subgroups with regard to sex distribution, mean age, or the presence of 
systemic disease. The only significant difference was related to the 
management and duration of diabetes mellitus. 
 The mean duration of diabetes was 4.8% in the ‘no change’ group  and 
10.4% in the ‘progression’ group Among the ‘no change’ group the diabetes 
was controlled by hypoglycemic agents in a greater number of patients(78%), 
whereas a greater number of patients whose retinopathy progressed needed  
insulin(35%) for management of diabetes  
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DISCUSSION 
 The aims of this study were 
(1)  to find out if  the operated  eyes of diabetic patients who undergo 
cataract surgery are   more prone than non-operated eyes  of   the  same  
patients to develop or to show progression of diabetic  retinopathy; 
(2)  to identify   the risk factors for postoperative progression of diabetic 
retinopathy; and 
 (3)  to  follow the course of the disease in this particular group of operated  
patients. 
 To achieve the last objective we   attempted to eliminate any factors that 
might  affect the natural course of the disease postoperatively. 
 Accordingly, we excluded from the  study group eyes with any 
additional diseases such as glaucoma or macular diseases other than  diabetes,  
or eyes treated by  laser photocoagulation  before or immediately after surgery 
for  pre existing  PDR  or  severe  NPDR or CSME. Thus at the time of surgery 
the eyes in our study group  presented only with   No DR or mild to moderate 
NPDR. The differentiation between aphakic or pseudophakic cystoid macular 
oedema and  diabetic cystoid macular oedema is  a major problem. In this 
series 'progression' of diabetic  retinopathy was defined only where worsening 
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of  the characteristics typical for diabetic retinopathy were observed, regardless 
of whether foveal cystoid oedema was present or not.  
 Thus  patients with cystoid macular oedema, but with no evidence of 
other characteristics of diabetic  retinopathy, were included in the 'no change'  
group.  Within 12 months of surgery diabetic retinopathy progressed in 40.4% 
of eyes that under-went cataract extraction as compared with only 14.3% in 
non- operated eyes over the same period  (Table 3). The incidence of 
progression of diabetic retinopathy in our  control group is in line with that 
reported by Pollock  who studied the course of  diabetic retinopathy over a one-
year  period in the general diabetic population aged 30 or older at the time of 
disease onset. 
 Since the  pre-eminent risk variable for the occurrence of  any diabetic 
retinopathy is thought   to be the  duration of the disease,  this  fact should be 
kept in  mind when planning cataract surgery for   diabetic  patients. 
 Pollock  et al also found 9%  of  operated  eyes and 4.3% of  non 
operated  eyes having  of new onset  of retinopathy in patients who had been 
free of  retinopathy  at the start of  the  study.In  our  study    only  5% of  
operated  eyes  and  1.2%  of  non  operated  eyes  had  new  onset  of  
retinopathy. 
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 The commonest pattern of progression  seen in our study   group was 
worsening of  pre-existing NPDR  (Table 6) which  was  similar  to the  study  
by  Pollock  et al. 
 Pollock et  al  found that  progression  of  retinopathy  occurred  nearly  
four  times(7/27)  as  often  in  eyes  with  pre existing  retinopathy  than  
without  it. In contrast we  found that retinal deterioration  occurred nearly  six 
times (5/29) as often in eyes with preexisting  diabetic retinopathy as without it 
(Table 5), thus pointing to the pre-existence of diabetic  retinopathy as a 
possible risk factor for its  postoperative  progression. 
 The more frequent deterioration of diabetic  retinopathy in our study 
group than in nonoperated  eyes of this and of  other series    appears to support 
earlier suggestions that  removal of the lens may result in a progression of   
diabetic retinopathy and/or development of  rubeosis iridis, in contrast to the 
findings reported by Sebestyen, who observed similar  progression of 
retinopathy in operated and nonoperated eyes. It is not yet clear how the 
removal  of the lens may affect diabetic retinal changes in  general.  
 However, with regard to one specific  characteristic ofdiabetic 
retinopathy - the occurrence  of endothelial proliferation and neovascularisation 
Williams et al showed that human  lens extracts can inhibit endothelial  
proliferation. Therefore their   removal may induce  vascular alterations 
resulting in neovascularisation.  
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 Furthermore they also  demonstrated considerable  inhibition of 
endothelial cell activity in  extracts of bovine lens capsule, and   suggested  that 
the presence of an intact lens capsule may inhibit the development of iris 
neovascularisation. 
 Clinical experience seems to support these  findings. 
 Aiello et al  found that, following ICCE,  patients with or without 
background retinopathy  were at particularly high risk of developing  vitreous 
haemorrhage, presumably reflecting  progression of the disease to PDR. Alparl  
and Pollock  et  al   observed deterioration of diabetic retinopathy in  some 
diabetic patients following either   ICCE or  ECCE, with the least progression 
occurring in  patients who underwent ECCE with IOL  implantation in the 
capsular bag.  Although  clinical evidence suggests that ICCE may have a  
more   deleterious effect than ECCE on the postoperative  course of diabetic 
retinopathy, the  precise role of the   posterior lens capsule in  reducing 
vascular complications after cataract  surgery in diabetic patients requires  
further  investigation. 
 Of the 34 eyes in our study that showed  postoperative retinal 
deterioration none  progressed  to PDR but remained at the non-proliferative 
stage, sometimes with postoperative  macular oedema, which affected the  final 
visual results. The visual outcome following cataract surgery in our study 
(Table 7) was  especially poor in patients with pre-existing  diabetic 
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retinopathy who showed postoperative progression; it should however be noted 
that in  the progression subgroup, good visual acuity was achieved in 60% of 
eyes with preoperative No DR and in 31% of eyes with preoperative NPDR. 
 The largest subgroup (88.9%) to achieve good  visual results consisted 
of patients with no preexisting diabetic retinopathy and no change  
postoperatively. 
 The only significant difference in general  clinical conditions between 
patients with no  change in retinal status and patients with postoperative  
progression of diabetic retinopathy  related to the management of diabetes  and 
duration of diabetes : more  patients in the 'progression' group than in the  'no 
change' group were managed by insulin and  had  longer  duration of  diabetes. 
 Other  factors which  influenced  postoperative  visual  outcome  were  
the  incidence  of  cystoid  macular  edema  (9.5%)  and  posterior  capsular  
opacification  (21.4%). 
 The results of this study clearly indicate that  progression of diabetic 
retinopathy is not  uncommon after cataract surgery, even when the  technique 
employed is ECCE. Patients with  diabetic retinopathy prior to surgery are at  
higher risk for progression. Accordingly these  patients should be closely 
monitored postoperatively  for early signs of progression of diabetic  
retinopathy and where necessary should be considered  candidates for laser 
treatment. Diabetic  patients scheduled for cataract extraction should  be 
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informed that surgery may have an adverse  influence on diabetic retinopathy 
and that this  may affect the final visual outcome. The preoperative  status of 
diabetic retinopathy may be a  significant prognostic factor for the 
postoperative  outcome. 
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CONCLUSION 
 
 
 Duration of diabetes plays a major role in the development of cataract. 
Cataract occurs more frequently in Type II  diabetics  of longer duration. 
 A good glycemic control during the perioperative period favourably 
influences the post operative visual outcome. 
 Cystoid macular edema and posterior  capsular opacification were the 
most frequent   postoperative complications. 
 Eyes with no evidence  of  diabetic  retinopathy  preoperatively  showed 
a significantly higher incidence of no change than of progression in  their  
postoperative retinal status. In eyes   with   preoperative  non proliferative 
diabetic  retinopathy  the opposite was true: their  postoperative retinal status 
showed a significantly higher incidence of progression than no  change.  
 The  incidence   of  the various patterns of progression observed one 
year after cataract surgery in the  study eye   with their corresponding incidence  
in the control eye showed higher percentage of progression of  non proliferative 
diabetic  retinopathy  in  both. 
 There  is a  significant  increase  in  aggravation of preexisting diabetic 
eye status in patients with poor  postoperative   glycemic control and long 
standing diabetes and in those with posterior capsular rent. 
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 Co existing systemic conditions do not play a major role in the visual 
recovery provided they are treated pre operatively. 
 Thus, cataract   surgery in diabetic patients results in a good visual 
outcome. 
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PROFORMA 
 
 
1. Name     : 
 
2. Age      : 
 
3. Sex      : 
 
4. IP No.     : 
 
5. Occupation    : 
  
6. Address     : 
  
7. Complaints  and  duration  :            
  
 
8. Diabetic status of  the  patient   
 a) Type  of diabetes   : 
    
 b) Duration  of  diabetes  : 
  
 c) Mode  of control of diabetes 
              Diet  and  exercise  : 
         
  Oral  hypoglycemic  agents : 
             
          Insulin   : 
 
9.Treatment for  diabetic  
 
   Retinopathy  (pre-op if any)  : 
 
10.  Assosciated  systemic illness  : 
11. Assosciated  ocular illness  : 
 
12. Vision                                        :      RE                LE 
  
a) With  pinhole               : 
  
b) Preliminary  vision      : 
 
c) subjective refraction    : 
 
13. Local  examination                    :      RE                LE 
 
Anterior segment     
            
               Lid     : 
               Conjunctiva   : 
               Cornea    : 
               AC     : 
                Iris     : 
                Pupil    : 
                Lens    : 
   
        
 
Fundus 
 
      Slit lamp biomicroscopy  :    
 
      Indirect  ophthalmoscopy  : 
 
14. Investigations 
 
Intraocular pressure     
(by applanation   tonometer)      : 
Urine 
         Albumin    : 
         Sugar     : 
Blood  sugar 
        Fasting     : 
 
        Postprandial    : 
 
        Blood  urea    : 
        
        Serum creatinine   : 
 
       Keratometry reading   : 
 
        A scan     :  
 
    
15. Surgical  notes  and  postoperative management 
 
        Date                                     : 
        
        Anaesthesia                         :                                                                                              
            
        RE/LE                                  : 
 
        ACIOL/PCIOL                     : 
 
        Surgery                                 : 
 
16. Intraoperative  complications 
 
                                                                                  
PC  tear  and its  management   : 
17. Postoperative  follow up 
 
 
 Weeks    
  1 
  
  2 
 
  3 
 
4 
 
5 
 
 6 
 
12 
 
24 
 
36 
 
48 
Vision  with pinhole           
Anterior  segment           
Refraction           
Fundus           
PC thickening           
YAG capsulotomy           
FFA           
Laser  photocoagulation           
    
18. Postoperative  complications   
Immediate 
Weeks    1    2   3    4    5    6 
Epithelial  erosions       
Striate  keratopathy       
Iritis       
Hyphaema       
Posterior  synechiae       
 
Late 
 
Weeks  
  1 
   
  2 
      
  4 
 
  6 
    
12 
   
  24 
   
36 
   
48 
Bullous  keratopathy         
High astigmatism         
Decentred lens         
Pigment  deposits         
Delayed 
endophthalmitis 
        
PC thickening         
CME          
Worsening of  DR         
19. Status  of diabetic  retinopathy 
   
       Operated  eye  : 
 
       Fellow  eye   : 
 
 
20.  Visual  outcome  :    
Pupillary  block       
Decentred lens       
Vitreous  haemorrhage       
CME       
Endophthalmitis       
ABBREVIATIONS 
 
 
ACIOL - Anterior chamber intraocular lens  
 
A Scan  - Amplitude Scan  
 
BA  - Bronchial Asthma  
 
CME  - Cystoid macular edema 
 
CSME - Clinically significant macular edema 
 
DM  -  Diabetes mellitus 
 
DR  - Diabetic retinopathy 
 
ECCE  - Extracapsular cataract extraction 
 
ETDRS - Early treatment for diabetic retinopathy study 
 
FFA  -  Fundus flourescein angiography  
 
H  - Haemorrhage 
 
HT   - Hypertension  
 
ICCE  - Intracapsular cataract extraction 
 
IHD   - Ischemic Heart Disease  
 
IRMA  - Intra retinal microvascular abnormality 
 
LE   - Left Eye  
  
Ma  - Microanuerysm 
 
No DR - No diabetic retinopathy 
 
NPDR   -  Non proliferative  diabetic retinopathy 
 
NVD  - Neovascularization disc 
 
PC  - Posterior Capsule 
 
PCO  - Posterior capsular opacification 
 
PCIOL -  Posterior chamber intraocular lens 
 
RE   - Right Eye  
 
SICS  - Small incision cataract surgery 
 
SRK  - Sanders Retzlaff  Kraff 
 
VB  - Venous  beading 
 
YAG  - Yttrium – Aluminium – Garnett  
 
MASTER CHART  
 
S 
No. 
 
Name 
 
Age 
 
Sex 
 
IP No 
Associated 
systemic 
disease 
 
Eye 
 
Vision 
Other 
eye 
vision 
Pre op DR 
status RE 
Pre op DR 
status 
LE 
Post op 
DR status 
RE 
Post op 
DR status 
LE 
Final 
Visual 
acuity 
1 Shanmugam 
 
74 M 375832  RE 6/60 6/36 M0D M0D SEVERE SEVERE 6/36 
2 Kuppan 
 
50 M 379245  LE 6/60 6/36 NO NO NO NO 6/60 
3 Lakshmanan 70 F 373539 HT RE 6/36 6/12 M0D M0D SEVERE M0D 6/60
4 George 
 
60 M 358252  LE 6/24 6/9 NO NO NO NO 6/6
5 Panchalai 
 
60 F 17230  LE 6/24 6/9 M0D M0D M0D M0D 6/12
6 Dillirani 
 
68 F 17232 HT RE 6/36 6/18 M0D M0D M0D M0D 6/18 
7 Mari 
 
52 F 17740  LE 6/24 6/12 NO NO NO NO 6/12 
8 Shanthi 
 
56 F 18521    LE 6/60 6/36 MILD MILD MILD M0D 6/60 
9 Rani 
 
52 F 18774   LE 6/36 6/18 NO NO NO NO 6/12 
10 Pushpa 
 
45 F 18589    RE 4/60 6/60 NO NO NO NO 6/12 
11 Vanasakshi 
 
44 F 19813  LE 6/60 6/36 NO NO NO NO 6/12 
12 Kanmani 
 
52 F 20876  RE 6/36 6/24 MILD MILD MILD MILD 6/12 
13 Selvakumar 
 
52 M 20895   LE 5/60 6/60 MILD MILD MILD MILD 6/12 
14 Mani 
 
70 M 20882 HT,IHD RE 6/60 6/36 M0D M0D SEVERE SEVERE 6/60 
 
 
S 
No. 
 
Name 
 
Age 
 
Sex 
 
IP No 
Associated 
systemic 
disease 
 
Eye 
 
Vision 
Other 
eye 
vision 
Pre op DR 
status RE 
Pre op DR 
status 
LE 
Post op 
DR status 
RE 
Post op 
DR status 
LE 
Final 
Visual 
acuity 
15 Rukmani 
 
55 F 21870   HT LE 6/60 6/60 MILD MILD MILD MILD 6/24 
16 Krishnamoorthy 
 
50 M 21861  LE 6/24 6/12 NO NO NO NO 6/12 
17 Manohari 
 
55 F 21863  RE 6/60 6/36 MILD MILD M0D MILD 6/18 
18 Venkatesan 
 
44 M 22543    LE 5/60 6/60 NO NO NO NO 6/18 
19 Selvaraj 
 
45 M 22618  RE 6/36 6/18 NO NO NO NO 6/12 
20 Indirani 
 
58 F 22168 HT LE 6/36 6/18 MILD MILD MILD MILD 6/12 
21 Singaram 
 
56 M 25281  RE 6/60 6/36 NO NO NO NO 6/12 
22 Swamy 
 
60 M 26466  LE 6/60 6/36 MILD MILD M0D M0D 6/18 
23 Alamelu 
 
38 F 19235  RE 6/36 6/12 NO NO NO NO 6/9
24 Dhanam 
 
48 F 8892  LE 6/24 6/9 NO NO NO NO 6/6
25 Natarajan 
 
67 M 27318  LE 6/24 6/9 MILD MILD M0D M0D 6/24 
26 Chandran 
 
50 M 27913 HT,BA RE 6/36 6/18 NO NO NO NO 6/12 
27 Manjula 
 
33 F 28782  LE 6/24 6/12 NO NO NO NO 6/12 
28 Anwar 
 
60 M 0853    LE 6/60 6/36 M0D M0D M0D M0D 6/12 
29 Rani 
 
52 F 29264   LE 6/36 6/18 NO NO NO NO 6/12 
 
 
S 
No. 
 
Name 
 
Age 
 
Sex 
 
IP No 
Associated 
systemic 
disease 
 
Eye 
 
Vision 
Other 
eye 
vision 
Pre op DR 
status RE 
Pre op DR 
status 
LE 
Post op 
DR status 
RE 
Post op 
DR status 
LE 
Final 
Visual 
acuity 
30 Ajirabee 
 
55 F 1396    RE 4/60 6/60 MILD MILD MILD MILD 6/36 
31 Subramanian 
 
80 M 2211  LE 6/60 6/36 MILD MILD M0D M0D 6/36 
 
 
32 Nagammal 
 
55 F 16609  RE 6/36 6/24 NO NO MILD NO 6/12 
33 Anandhan 
 
66 M 3151   LE 5/60 6/60 M0D M0D M0D SEVERE 6/60 
34 Santhanalakshmi 
 
70 F 3009 HT RE 6/60 6/36 MILD MILD M0D M0D 6/36 
35 Vengammal 
 
60 F 4220   HT LE 6/60 6/60 MILD MILD MILD M0D 6/12 
36 Anjali 
 
50 F 3886  LE 6/24 6/12 NO NO NO NO 6/12 
37 Vijayarani 
 
50 F 4077  RE 6/60 6/36 MILD MILD M0D M0D 6/24 
38 Esther 
 
44 F 5254    LE 5/60 6/60 NO NO NO NO 6/12 
39 Ethiraj 
 
62 M 5136  RE 6/36 6/18 MILD MILD M0D MILD  
6/12 
40 Thulasi 
 
65 F 5756 HT LE 6/36 6/18 MILD MILD MILD MILD 6/12 
41 Devagi 
 
60 F 3242  RE 6/60 6/36 MILD MILD MILD MILD 6/12 
42 Lakshmi 
 
60 F 5857  LE 6/60 6/36 MILD MILD MILD M0D 6/12
43 Selvam 
 
56 M 6107  RE 6/36 6/12 NO NO NO NO 6/9
44 Padma 
 
50 F 7192  LE 6/24 6/9 NO NO NO NO 6/6
S 
No. 
 
Name 
 
Age 
 
Sex 
 
IP No 
Associated 
systemic 
disease 
 
Eye 
 
Vision 
Other 
eye 
vision 
Pre op DR 
status RE 
Pre op DR 
status 
LE 
Post op 
DR status 
RE 
Post op 
DR status 
LE 
Final 
Visual 
acuity 
45 Padmavathi 
 
55 F 6878  LE 6/24 6/9 NO NO NO NO 6/12
46 Rajeshwari 
 
54 F 5868  RE 6/36 6/18 NO NO NO NO 6/12 
47 Arammal 
 
60 F 6869  LE 6/24 6/12 NO NO NO NO 6/12 
 
 
48 Agustin 
 
71 M 6732   HT LE 6/60 6/36 M0D M0D SEVERE SEVERE 6/60 
 
49 Maasilamani 
 
55 M 7719   LE 6/36 6/18 NO NO NO NO 6/12 
50 Ulaganathan 
 
65 M 7749   HT RE 4/60 6/60 M0D M0D SEVERE M0D 6/60 
51 Saraswathy 
 
60 F 7746  LE 6/60 6/36 MILD MILD M0D M0D 6/12 
52 Rajamani 
 
55 F 6336  RE 6/36 6/24 NO NO NO NO 6/12 
53 Ramamoorthy 
 
73 M 8231   HT,IHD LE 5/60 6/60 M0D M0D M0D SEVERE 6/60 
54 Arumugam 
 
57 M 29603  RE 6/60 6/36 MILD MILD MILD MILD 6/12 
55 Gajendiran 
 
74 M 32971   HT LE 6/60 6/60 MILD MILD MILD M0D 6/18 
56 Kala 
 
40 F 30397  LE 6/24 6/12 NO NO NO NO 6/12 
57 Panjali 
 
65 F 31282  RE 6/60 6/36 MILD MILD M0D M0D 6/12 
58 Thesammal 
 
67 F 31568   HT LE 5/60 6/60 M0D M0D M0D SEVERE 6/60 
59 Jayashree 
 
60 F 22137  RE 6/36 6/18 NO NO MILD NO 6/60 
 
S 
No. 
 
Name 
 
Age 
 
Sex 
 
IP No 
Associated 
systemic 
disease 
 
Eye 
 
Vision 
Other 
eye 
vision 
Pre op DR 
status RE 
Pre op DR 
status 
LE 
Post op 
DR status 
RE 
Post op 
DR status 
LE 
Final 
Visual 
acuity 
60 Kamatchi 
 
58 F 43401  LE 6/36 6/18 NO NO NO NO 6/12 
61 Dhanapal 
 
52 M 32423  RE 6/60 6/36 NO NO NO NO 6/12 
62 Kuppusamy 
 
70 M 38291  LE 6/60 6/36 MILD MILD MILD M0D 6/12
63 Fathima 
 
42 F 24190  RE 6/36 6/12 NO NO NO NO 6/9
64 Dharani 
 
35 M 26337  LE 6/24 6/9 NO NO NO NO 6/6 
 
65 Navaneetham 
 
45 M 26083  LE 6/24 6/9 NO NO NO NO 6/12
66 Kothandam 
 
50 M 27725 BA RE 6/36 6/18 NO NO NO NO 6/24 
67 Lakshmi 
 
45 F 28621  LE 6/24 6/12 NO NO NO NO 6/12 
68 Gangadharan 
 
56 M 29489   HT LE 6/60 6/36 M0D M0D M0D M0D 6/60 
69 Saraswathy 
 
55 F 30242   LE 6/36 6/18 NO NO NO NO 6/12 
70 Govindaraj 
 
67 M 31155   HT RE 4/60 6/60 M0D M0D SEVERE M0D 6/36 
71 Soundararajan 
 
66 M 31446  LE 6/60 6/36 MILD MILD M0D M0D 6/60 
72 Amaravathy 
 
65 F 32340  RE 6/36 6/24 NO NO MILD MILD 6/18 
73 Selvaperumal 
 
71 M 32310   HT,IHD LE 5/60 6/60 M0D M0D M0D SEVERE 6/60 
74 Sivamugan 
 
51 M 33027  RE 6/60 6/36 MILD MILD MILD MILD 6/12 
 
 
S 
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IP No 
Associated 
systemic 
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Pre op DR 
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LE 
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RE 
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LE 
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75 Joseph 
 
72 M 32871   HT LE 6/60 6/60 MILD MILD MILD M0D 6/12 
76 Premkumari 
 
43 F 34039  LE 6/24 6/12 NO NO NO NO 6/12 
77 Paramasivam 
 
65 M 34062  RE 6/60 6/36 MILD MILD M0D M0D 6/12 
78 Venkatesan 
 
67 M 35812   HT LE 5/60 6/60 M0D M0D M0D SEVERE 6/60 
79 Selvaraj 
 
45 M 36423  RE 6/36 6/18 NO NO NO NO 6/12 
80 MadinaBeevi 
 
61 F 36780  LE 6/36 6/18 NO NO NO MILD 6/12 
81 Sivakumar 
 
60 M 5756  RE 6/60 6/36 MILD MILD M0D M0D 6/12 
82 Murugesan 
 
66 M 6732   HT LE 5/60 6/60 M0D M0D M0D M0D 6/12 
83 Selvaperumal 
 
50 M 11064  RE 6/36 6/18 NO NO NO NO 6/18 
 
84 Maheshwari 
 
55 F 45929  LE 6/36 6/18 NO NO NO MILD 6/12 
 
 
 
 
 
 
LIST  OF  SURGERIES  PERFORMED 
 
 
Sl. 
No. 
Name Age Sex Hosp. 
No. 
Diagnosis Surgery 
1 Devaraj  55 M 3215 RE Mature  
cataract
ECCE with 
PCIOL 
2 Noorjahan 60 F 9923 LE Mature  
cataract 
ECCE with 
PCIOL 
3 Rajammal 65 F 10124 LE Mature  
cataract  
ECCE with 
PCIOL 
4 Venkatesan 50 M 10774 RE 
Panophthalmitis 
with  anterior  
staphyloma
Evisceration 
5 Saroja 60 F 11552 RE 
Phacophormic 
glaucoma
ECCE with 
PCIOL 
6 Jeyaraman 60 M 13040 RE Chronic 
dacryocystitis 
Dacryocystectomy
7 Arumugam 60 M 13209 RE Mature  
cataract
ECCE with 
PCIOL 
8 Kasthuri 
 
22 F 178332 LE Lower lid 
Chalazion 
Incision and  
curettage
9 Devammal 54 F 16289 RE Immature  
cataract
ECCE with 
PCIOL 
10 Rani 68 F 14628 LE Immature  
cataract
ECCE with 
PCIOL 
11 Mohanambal 70 F 14560 RE Mature  
cataract
ECCE with 
ACIOL 
12 Muthu 40 M 14645 RE Nasal 
pterygium 
Pterygium 
excision with 
autograft
13 Thangamalai 62 M 14668 RE Nuclear 
sclerosis
ECCE with 
PCIOL 
14 Vasudeiah 60 M 22402 RE  Immature  
cataract
 SICS with 
PCIOL 
15 Lakshmi 65 F 180554 RE Nuclear 
sclerosis
 SICS with 
PCIOL 
16 Kadarkalaiselvan 60 M 23699 LE 
Phacomorphic 
glaucoma
 ECCE with 
PCIOL  with 
trabeculectomy
17 Shanmugam 73 M 28301 LE Lmmature 
cataract
 SICS with 
ACIOL 
Sl. 
No. 
Name Age Sex Hosp. 
No. 
Diagnosis Surgery 
18 Nagappan 70 M 29244 LE Mature 
cataract
 SICS with 
PCIOL 
19 Lakshmi 55 F 10493 LE 
Lagophthalmos 
Tarsorrhaphy 
20 Jeevarathinam 65 F 40765 RE Nuclear 
sclerosis
 SICS with 
PCIOL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
POSTERIOR SUBCAPSULAR CATARACT  
PRE OPERATIVE MODERATE NON 
PROLIFERATIVE DIABETIC RETINOPATHY 
(OPERATED EYE)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PROGRESSED TO SEVERE NON 
PROLIFERATIVE DIABETIC RETINOPATHY 
AFTER SURGERY  
PRE OPERATIVE MODERATE NON 
PROLIFERATIVE DIABETIC RETINOPATHY 
 (NON OPERATED EYE)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PROGRESSED TO SEVERE NON 
PROLIFERATIVE DIABETIC RETINOPATHY 
AFTER SURGERY (NON OPERATED EYE) 
 
 
 
 
 
 
 
 
NORMAL POST OPERATIVE EYE 
 
 
 
 
ANTERIOR CHAMBER INTRA OCULAR LENS 
IMPLANTATION DUE TO POSTERIOR 
CAPSULAR TEAR  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CLINICALLY SIGNIFICANT  
MACULAR EDEMA  
 
 
 
 
 
FUNDUS FLUORESCEIN ANGIOGRAPHY OF 
NON PROLIFERATIVE DIABETIC 
RETINOPATHY WITH MACULAR EDEMA  
 
 
CYSTOID MACULAR EDEMA  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FUNDUS FLUORESCEIN ANGIOGRAPHY OF 
CYSTOID MACULAR EDEMA  
 
 
 
 
 
 
 
 
STRIATE KERATOPATHY  
 
 
